Advisory Services Network’s Castle Biosciences CSTL Stock Holding History

Advisory Services Network’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-287	Closed	-$7.05K	–	2690
2026 Q1	$7.05K	Buy	+287	New	+$9.4K	﹤0.01%	3718
2025 Q4	–	Sell	-7	Closed	-$159	–	2338
2025 Q3	$159	Buy	+7	New	+$142	﹤0.01%	4261
2023 Q2	–	Sell	-38	Closed	-$863	–	1914
2023 Q1	$863	Hold	38	–	–	﹤0.01%	3640
2022 Q4	$895	Buy	+38	New	+$881	﹤0.01%	3613
2021 Q3	–	Sell	-1,641	Closed	-$120K	–	1788
2021 Q2	$120K	Buy	+1,641	New	+$108K	﹤0.01%	1508
2021 Q1	–	Sell	-306	Closed	-$20K	–	1627
2020 Q4	$20K	Sell	306 -294	-49%	-$15.9K	﹤0.01%	2146
2020 Q3	$31K	Buy	+600	New	+$26.7K	﹤0.01%	1833

Other funds holding CSTL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's CSTL Position: Q2 2026 in Review

Advisory Services Network sold out of Castle Biosciences (CSTL) in Q2 2026, closing a stake of 287 shares — an estimated $7.05K sold.

Advisory Services Network first reported a position in CSTL in Q3 2020 and held it in 7 quarters. The position peaked at $120K in Q2 2021. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

Advisory Services Network reported no remaining Castle Biosciences position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 287 Castle Biosciences shares in Q2 2026, an estimated $7.05K.
Advisory Services Network first reported a position in Castle Biosciences in Q3 2020 and held it in 7 quarters.
Advisory Services Network's Castle Biosciences position peaked at $120K in Q2 2021.
177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.